Peripheral vascular disease in diabetic peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 27, Issue SUPPL. 2, 2007, Pages

  Saha, Heikki H T ^a,b   Leskinen, Yrjö K J ^c   Salenius, Juha P ^a   Lahtela, Jorma T ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Diabetes; Peripheral vascular disease

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; DIAGNOSTIC IMAGING; FOOT AMPUTATION; GANGRENE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; KIDNEY FAILURE; KINESIOTHERAPY; LIFESTYLE; LIMB SALVAGE; PATIENT ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; PERIPHERAL VASCULAR DISEASES; PERITONEAL DIALYSIS; PREVALENCE; RISK FACTORS;

EID: 35748965899     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. O'Hare AM. Management of peripheral arterial disease in chronic kidney disease. Cardiol Clin 2005; 23:225-36.
2. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 3):S1-153.
3. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet 2005; 366:1725-35.
4. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA. Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 1993; 7:523-7.
5. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002; 40:472-9.
6. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complicationsin non-insulin-dependent diabetes meltitus. Arterioscler Thromb Vasc Biol 1996; 16: 978-83.
7. Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, Maezawa A, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003; 14:1591-8.
8. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 1996; 27:668-72.
9. Martin C, Montes R, Guerrero A, Lopez R, Cabello V, Bernal G. Peripheral vascular disease in CAPD. Peril Dial Int 1996; 16:529-31.
10. Webb AT, Brown EA. Prevalence of symptomatic arterial disease and risk factors for its development in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2):S406-8.
11. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-62.
12. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002; 13:497-503.
13. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int 2003; 63: 1462-7.
14. Wakeen M, Zimmerman SW. Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 1998; 32:488-93.
15. Lipscombe J, Jassal SV, Bailey S, Bargman JM, Vas S, Oreopoulos DG. Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int 2003; 23:255-9.
16. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15:1014-21.
17. Boaz M, Weinstein T, Matas Z, Green M, Smetana S. Peripheral vascular disease and serum phosphorus in hemodialysis: a nested case-control study. Clin Nephrol 2005; 63:98-105.
18. Chan CT, Mardirossian S, Faratro R, Richardson RM. Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis. Am J Kidney Dis 2003; 41: 225-9.
19. Eggers PW, Gohdes D, Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 1999; 56:1524-33.
20. Logar CM, Pappas LM, Ramkumar N, Beddhu S. Surgical revascularization versus amputation for peripheral vascular disease in dialysis patients: a cohort study. BMC Nephrol 2005; 6:3 (8 pp).
21. Foster AV, Snowden S, Grenfell A, Watkins PJ, Edmonds ME. Reduction of gangrene and amputations in diabetic renal transplant patients: the role of a special foot clinic. Diabet Med 1995; 12:632-5.
22. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941-51.
23. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295:547-53.
24. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
25. Brosi P, Baumgartner I, Silvestro A, Do DD, Mahler F, Triller J, et al. Below-the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther 2005; 12:704-13.
26. Korn P, Hoenig SJ, Skillman JJ, Kent KC. Is lower extremity revascularization worthwhile in patients with end-stage renal disease? Surgery 2000; 128:472-9.